Related Experiment Video
Updated: Jun 6, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Recognition and management of sleep-disordered breathing in chronic heart failure
Rami Kahwash1, Donald Kikta, Rami Khayat
1Division of Cardiovascular Medicine, Section of Heart Failure and Transplant, Davis Heart/Lung Research Institute, 473 West 12th Avenue, Columbus, OH 43210, USA. Rami.Kahwash@osumc.edu
Abstract:
It is increasingly recognized that sleep-disordered breathing (SDB) is a common modifiable risk factor for cardiovascular disease with significant impact on morbidity and potentially mortality. SDB is highly prevalent in patients with systolic or diastolic heart failure. A high index of suspicion is necessary to diagnose SDB in patients with heart failure because the vast majority of affected patients do not report daytime symptoms. Recent clinical trials have demonstrated improvement in heart function, exercise tolerance, and quality of life after treatment of SDB in patients with heart failure. Accumulating evidence suggests that treatment of SDB should complement the established pharmacologic therapy for chronic heart failure. However, mortality benefit has yet to be demonstrated.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Sleep Apnea
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Heart Failure IV: Classification and Diagnostic Evaluation